| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |